Indeed, enhancing lysosomal-mediated proteolysis by overexpressing transcription factor EB (TFEB) in neuromelanin-producing rats was shown to reduce the intracellular neuromelanin density, attenuate PD-like inclusion formation, prevent nigrostriatal neurodegeneration, and reverse motor impairment [18]. This evidence concerns the gene TFEB and Parkinson disease.